Enlivex Therapeutics Ownership | Who Owns Enlivex Therapeutics?

Enlivex Therapeutics Ownership Summary

Enlivex Therapeutics is owned by 2.46% institutional investors, 0.46% insiders, and 97.08% retail investors. Millennium management is the largest institutional shareholder, holding 2.98% of ENLV shares. ARK Israel Innovative Technology ETF is the top mutual fund, with 0.26% of its assets in Enlivex Therapeutics shares.

ENLV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Enlivex Therapeutics	2.46%	0.46%	97.08%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Millennium management	633.85K	2.98%	$741.60K
Renaissance	313.63K	1.30%	$220.54K
Morgan stanley	200.63K	0.83%	$141.08K
Hrt financial lp	153.99K	0.64%	$108.00K
Jane street group	74.08K	0.31%	$52.09K
Xtx topco	42.67K	0.18%	$44.38K
Ubs group	34.99K	0.15%	$24.60K
Two sigma securities	34.24K	0.14%	$35.61K
Prosperity consulting group	17.65K	0.07%	$18.35K
Susquehanna group, llp	11.16K	0.05%	$13.06K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Two sigma securities	34.24K	0.01%	$35.61K
Xtx topco	42.67K	0.00%	$44.38K
Prosperity consulting group	17.65K	0.00%	$18.35K
Millennium management	633.85K	0.00%	$741.60K
Hrt financial lp	153.99K	0.00%	$108.00K
Renaissance	313.63K	0.00%	$220.54K
Bfsg	1.00K	0.00%	$704.00
Activest wealth management	1.00K	0.00%	$703.00
Citizens financial group inc/ri	-	-	-
Geode capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	633.85K	0.00%	633.85K
Renaissance	313.63K	0.00%	156.34K
Hrt financial lp	153.99K	0.00%	135.20K
Jane street group	74.08K	-	52.55K
Xtx topco	42.67K	0.00%	42.67K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.41M
Citizens financial group inc/ri	-	-	-231.42K
Citadel advisors	-	-	-55.52K
Sigma investment counselors	-	-	-28.00K
Virtu financial	-	-	-17.45K

New Positions

Holder	Shares	% Assets	Change	Value
Millennium management	633.85K	0.00%	633.85K	$741.60K
Xtx topco	42.67K	0.00%	42.67K	$44.38K
Prosperity consulting group	17.65K	0.00%	17.65K	$18.35K
Susquehanna group, llp	11.16K	-	11.16K	$13.06K
Two sigma investments, lp	10.74K	-	10.74K	$11.17K

Sold Out

Holder	Change
Qube research	-1.00
Sbi securities	-1.00
Global retirement partners	-11.00
Raymond james financial	-57.00
Spire wealth management	-500.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	10	-64.29%	590,338	-34.73%	2	17.08%	6	-50.00%	1	-80.00%
Sep 30, 2025	12	-40.00%	287,663	-87.72%	1	1.05%	2	-60.00%	1	-83.33%
Jun 30, 2025	22	-21.43%	2,557,493	-19.40%	11	5.56%	5	-44.44%	8	14.29%
Mar 31, 2025	27	3.85%	3,162,878	-7.25%	14	5.62%	8	-55.56%	7	133.33%
Dec 31, 2024	11	-47.62%	53,240	-97.92%	-	0.15%	7	-22.22%	2	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Israel Innovative Technology ETF	628.31K	0.26%	-
Dolphin 90/10 IL	43.48K	0.20%	-
MTF TR TA-Growth	37.59K	0.17%	-1.46K
IBI Mehaka TA-Growth	13.30K	0.06%	-80.00
Dolphin Flexible	7.42K	0.03%	-
Invesco NASDAQ Future Gen 200 ETF	68.17K	0.03%	-
I.B.I 90/10	5.75K	0.03%	-
Harel HTF TA All-Share IL	3.86K	0.02%	9.00
I.B.I Government + 10% IL	3.00K	0.01%	-
Dolphin75/25 IL	787.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 09, 2015	Murray Michael Anthony	former SVP - Operations	Sell	$156.76K

ENLV Ownership FAQ

Who Owns Enlivex Therapeutics?

Enlivex Therapeutics shareholders are primarily institutional investors at 2.46%, followed by 0.46% insiders and 97.08% retail investors. The average institutional ownership in Enlivex Therapeutics's industry, Biotech Stocks , is 381.47%, which Enlivex Therapeutics falls below.

Who owns the most shares of Enlivex Therapeutics?

Enlivex Therapeutics’s largest shareholders are Millennium management (633.85K shares, 2.98%), Renaissance (313.63K shares, 1.30%), and Morgan stanley (200.63K shares, 0.83%). Together, they hold 5.12% of Enlivex Therapeutics’s total shares outstanding.

Does Blackrock own Enlivex Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Enlivex Therapeutics.

Who is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested?

Two sigma securities is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 34.24K Enlivex Therapeutics shares, valued at 35.61K$.

Who is the top mutual fund holder of Enlivex Therapeutics shares?

ARK Israel Innovative Technology ETF is the top mutual fund holder of Enlivex Therapeutics shares, with 0.26% of its total shares outstanding invested in 628.31K Enlivex Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools